Patrice P. Denefle
Chief Tech/Sci/R&D Officer presso CENTOGENE N.V.
Profilo
Patrice P.
Denefle is currently the Chief Scientific Officer at Centogene NV since 2021.
Prior to this, he held the same position at Genethon and 4P-Pharma.
He completed his undergraduate degree at Université De Lille.
Posizioni attive di Patrice P. Denefle
| Società | Posizione | Inizio |
|---|---|---|
| CENTOGENE N.V. | Chief Tech/Sci/R&D Officer | 16/08/2021 |
Precedenti posizioni note di Patrice P. Denefle
| Società | Posizione | Fine |
|---|---|---|
| 4P-Pharma | Chief Tech/Sci/R&D Officer | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - |
Formazione di Patrice P. Denefle
| Université De Lille | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| Aziende private | 2 |
|---|---|
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
| 4P-Pharma |
- Borsa valori
- Insiders
- Patrice P. Denefle
